Relationship study between c-MET protein expression and c-met rearrangement in advanced non-small cell lung cancer

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000030571

Enrollment

Unknown

Registered

2020-03-07

Start date

2020-04-01

Completion date

Unknown

Last updated

2020-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

case series:N/A

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: A. Cytological or histological confirmation of non-small cell lung cancer; B. ECOG score between 0 to 2 ; C. Patients with stage IIIB to IV according to the latest TNM staging; D. Did not receive tumor-related treatment; E. Age 18 or above, regardless of gender; F. At least one measurable lesion; G. At least 10 paraffin tissue specimens of tumor can be collected (more than 30% of tumor cells in the sections). H. Sign the informed consent.

Exclusion criteria

Exclusion criteria: A. Any signs of toxic or uncontrolled systemic disease that are considered in the study to be likely to significantly alter the balance of risk/benefit to the patient; B. Patients do not agree to use existing medical data for scientific research and to share it with national big data; C. False and incomplete samples of information records in the registration form;

Design outcomes

Primary

Measure	Time frame
PFS;Expression of c-met protein;c-met gene copy numbers ;c-met gene mutation;	—

Countries

China

Contacts

Public ContactLi Ma

Beijing Chest Hospital

silenceli2013@163.com+86 15810209360

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026